Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biomarin Pharmaceuticals (NQ: BMRN ) 84.82 +0.16 (+0.19%) Streaming Delayed Price Updated: 12:49 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 496,487 Open 84.83 Bid (Size) 84.76 (2) Ask (Size) 84.89 (4) Prev. Close 84.66 Today's Range 84.38 - 86.24 52wk Range 73.67 - 99.56 Shares Outstanding 183,352,255 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News $1000 Invested In This Stock 20 Years Ago Would Be Worth $16,000 Today July 16, 2024 Via Benzinga Peering Into Biomarin Pharmaceutical's Recent Short Interest July 04, 2024 Via Benzinga Performance YTD -13.49% -13.49% 1 Month -0.24% -0.24% 3 Month -6.25% -6.25% 6 Month -9.22% -9.22% 1 Year -1.69% -1.69% More News Read More Investors should take note of NASDAQ:BMRN, a growth stock that remains attractively priced. July 02, 2024 Via Chartmill Cracking The Code: Understanding Analyst Reviews For Biomarin Pharmaceutical June 27, 2024 Via Benzinga For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering. June 11, 2024 Via Chartmill CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump June 07, 2024 Via Investor's Business Daily Topics Stocks Exposures US Equities Looking Into Biomarin Pharmaceutical's Recent Short Interest May 28, 2024 Via Benzinga June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge June 05, 2024 Via InvestorPlace 10 Health Care Stocks Whale Activity In Today's Session June 04, 2024 Via Benzinga BridgeBio Stock Makes A Bullish Move On Dwarfism Treatment Results June 04, 2024 Via Investor's Business Daily NASDAQ:BMRN is not too expensive for the growth it is showing. May 21, 2024 Via Chartmill Li Auto Was One Of The Worst-Performing Stocks Last Week: Are These 10 Large-Cap Stocks Losers In Your Portfolio? (May 12-May 18, 2024) May 19, 2024 Via Benzinga Analyst Ratings For Biomarin Pharmaceutical May 14, 2024 Via Benzinga (BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest May 09, 2024 Via Benzinga Deep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings) April 25, 2024 Via Benzinga 4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market May 18, 2024 Via The Motley Fool Topics Stocks Exposures US Equities Walmart To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday May 17, 2024 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session May 15, 2024 Via Benzinga The 3 Best Biotech Stocks to Buy in May 2024 May 09, 2024 Via InvestorPlace Citi Just Cut Its Price Target on These 3 Stocks May 03, 2024 Via InvestorPlace For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering. April 30, 2024 Via Chartmill 4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market April 27, 2024 Via The Motley Fool Topics Stocks Exposures US Equities 3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition April 25, 2024 Via InvestorPlace BMRN Stock Earnings: Biomarin Pharmaceutical Beats EPS, Misses Revenue for Q1 2024 April 24, 2024 Via InvestorPlace Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 25, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
